Decreased therapeutic effects of noscapine combined with imatinib mesylate on human glioblastoma in vitro and the effect of midkine

dc.contributor.author	Erguven, Mine
dc.contributor.author	Bilir, Ayhan
dc.contributor.author	Yazihan, Nuray
dc.contributor.author	Ermis, Ezgi
dc.contributor.author	Sabanci, Akin
dc.contributor.author	Aktas, Esin
dc.contributor.author	Aras, Yavuz
dc.contributor.author	Alpman, Vehbi
dc.date.accessioned	2021-12-21T08:46:57Z
dc.date.available	2021-12-21T08:46:57Z
dc.date.issued	2011
dc.identifier.issn	1475-2867
dc.identifier.uri	https://doi.org/10.1186/1475-2867-11-18
dc.identifier.uri	http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/2136
dc.description.abstract	Background: Glioblastoma (GBM) develops resistance to the advances in chemotherapy leading to poor prognosis and life quality. Consequently, new treatment modalities are needed. Our aims were to investigate the effects of combined noscapine (NOS) and imat
dc.description.sponsorship	Istanbul UniversityIstanbul University [T988/06102006]
dc.language.iso	English
dc.publisher	Bmc
dc.rights	Green Published, gold
dc.title	Decreased therapeutic effects of noscapine combined with imatinib mesylate on human glioblastoma in vitro and the effect of midkine
dc.type	Article
dc.relation.journal	Cancer Cell Internatıonal
dc.identifier.volume	11
dc.identifier.doi	10.1186/1475-2867-11-18
dc.relation.volume	11

Files in this item

Files	Size	Format	View
There are no files associated with this item.